EYE FOCUS | COVER STORY
“...we expect to see a continuous
increase in the investment of
contact lens and lens care
research and development to
help improve the overall lens-
wearing experience of patients.”
According to Dr. Buch, Johnson & Johnson is
looking at a lens that may one day alleviate the
nagging symptoms of allergy sufferers.
“Among investigational products are contact
lenses that are being developed through novel
drug-delivery manufacturing technology. We
believe these lenses could be the world’s first
antihistamine-releasing vision-correcting con-
tact lenses to aid those with ocular allergies.”
Johnson & Johnson is also committed to halting
the myopia epidemic.
The company’s internal soft contact lens clinical
program for myopia received FDA breakthrough
designation in the summer of 2019.
10 EYE FOCUS February Digital 2020
Bausch + Lomb’s Matt Nowak believes the coming
years will be an exciting time for eye care.
“Influenced by dynamic demographics and the
changing digital world we live in, and we expect to
see a continuous increase in the investment of con-
tact lens and lens care research and development to
help improve the overall lens-wearing experience of
patients.”